CVS, FTC Reach Proposed Settlement in Insulin Pricing Case

CVS reaches FTC settlement over insulin pricing practices - The Boston Globe

The proposed settlement is subject to review and approval by the Federal Trade Commission chair.

FTC strikes proposed deal with CVS over charges its PBM manipulated insulin prices, impeded access

CVS says the proposed agreement is subject to review and approval by the FTC chair, and that final terms are still pending.

CVS reaches insulin pricing settlement with FTC

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced scrutiny from regulators and lawmakers over pricing practices.

CVS, FTC reach proposed settlement in insulin pricing case

A settlement between CVS' pharmacy benefit manager and antitrust regulators would leave UnitedHealth as the sole holdout in high-profile suit.